Home Sleep Testing in Neuromuscular Disease Patients

Status Completed

Clinical Trial Summary

Lay Summary Patients with severe neuromuscular develop hypoventilation, which leads to elevated carbon dioxide levels. Measuring only oxygen saturation levels with pulse oximetry may be inadequate. End tidal carbon dioxide levels or arterial blood gases should be measured periodically, depending on the clinical condition of the patient. A thorough review of systems will help define any problems. Patients who are hypoventilating often have elevated carbon dioxide levels at night and complain of a morning headache, restlessness or nightmares, and poor quality sleep. This may cause daytime sleepiness. Insufficient respiration with hypoxia may occur later, especially if the lung is damaged by chronic aspiration.

We propose to evaluate the use of the Nonin LifeSense monitor in home evaluation of respiration, oxygen level, heart rate, and carbon dioxide level and to develop interpretation of the results that will lead to appropriate interventions for apnea, and insufficient respiration.

Relevance to MDA Fewer than one per cent of the Muscular Dystrophy Association have pulmonologists as co-directors.Late referral of progressive restrictive lung disease leads to invasive support of respiratory failure. Early initiation of non invasive ventilation techniques requires patience on the part of the caregiver and exploration of mask interfaces and ventilation techniques. In addition, the development of new therapies, currently manifested through enhanced diagnostic accuracy, will require new signal for initiation and in the assessment of success or failure.

Aims Aim 1. To assess the utility of a small portable device (LifeSense Monitor Nonin Medical Inc. Plymouth Minnesota) with extended recording capabilty to provide accurate diagnosis of hypoventilation.

Aim 2. To provide an easily interpretable report defining sleep hypoxemia, hypercapnea, and apnea.

Aim 3. To promote early evaluation and treatment of the respiratory problems in centers that do not have pumonologists as these are essential to prognosis, whether of survival or of quality of life, in neuromuscular diseases.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00695591
Study type	Observational
Source	Landon Pediatric Foundation
Contact
Status	Completed
Phase	N/A
Start date	July 2008
Completion date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02847299` - Comparison of a Hyperinflation Mode and Air Stacking on Neuromuscular Patients Under Volumetric Ventilation	N/A
Completed	`NCT02551406` - Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients	N/A
Completed	`NCT00860951` - P300 Brain Computer Interface Keyboard to Operate Assistive Technology	Phase 1/Phase 2
Recruiting	`NCT02288299` - Long-Term Effect of LIAM on Respiratory Performance in NIV Patients Suffering From Neuromuscular Disease	N/A
Completed	`NCT02284022` - Clinical Validation Protocol for BCI for the Communication of Patients Suffering From Neuromuscular Disorders.	N/A
Completed	`NCT00001201` - Evaluation of Neuromuscular Disease	N/A
Completed	`NCT00252252` - AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation	Phase 1
Completed	`NCT02153970` - Calibration and Validation of the PROMIS and Neuro-QOL Questionnaires in Cerebral Palsy and Congenital Muscular Dystrophy
Terminated	`NCT02317042` - Juno Perth Clinical Trial	N/A
Terminated	`NCT02022072` - Evaluation of Vital Capacity	Phase 2
Recruiting	`NCT04417023` - B3 for NMD: Bench to Bedside and Back
Recruiting	`NCT02532244` - Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
Completed	`NCT01621984` - Therapeutic Riding and Neuromuscular Disease	Phase 1
Recruiting	`NCT01900132` - Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers	N/A
Completed	`NCT00017745` - Phenotype/Genotype Correlations in Neuromuscular Disorders	N/A
Recruiting	`NCT01560741` - Telemedicine and Ventilator Titration in Chronic Respiratory Patients Initiating Non-invasive Ventilation	Phase 1
Completed	`NCT01644162` - Ventilator Monitoring in Early Exacerbation Detection	N/A
Completed	`NCT01518439` - Instrumental and Manual Increase of Couch in Neuromuscular Patients	N/A
Completed	`NCT01611597` - Continuous Measurement of the Activity for Clinical Evaluation at Home, for Non-ambulant Neuromuscular Patients	N/A
Completed	`NCT01371149` - Patient -Ventilator Interaction in Chronic Respiratory Failure	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Home Sleep Testing in Neuromuscular Disease Patients — HSTNMD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms